thumbnail
Nucleus Network Acquires Hammersmith Medicines Research
Establishes First Truly Global Early-Phase Clinical Trial Network BRISBANE, Australia & LONDON--BUSINESS WIRE-- Nucleus Network, a global leader in early phase clinical research, today...
thumbnail
HESTA announces appointment of new Chief Risk Officer
4 August 2025HESTA has today announced the appointment of Natalie Alford as its new Chief Risk Officer, commencing on Monday 3 November.Ms Alford joins from Equip Super, where she has served as...